Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Storb

Showing results (261-270 of 315) with videos related to

Pageof 32
Sort By:
Blood|January 12, 2012
The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantationBart L Scott, Ted A Gooley, Mohamed L Sorror, et al.
Cancers|August 23, 2020
Conditioning Intensity, Pre-Transplant Flow Cytometric Measurable Residual Disease, and Outcome in Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell TransplantationLinde M Morsink, Brenda M Sandmaier, Megan Othus, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 12, 2010
Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia: relapse-free survival is determined by karyotype and comorbiditiesHesham Eissa, Ted A Gooley, Mohamed L Sorror, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 13, 2017
Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure DisordersLauri M Burroughs, Akiko Shimamura, Julie-An Talano, et al.
Blood|July 1, 2004
Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioningFrédéric Baron, Jennifer E Baker, Rainer Storb, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 9, 2007
Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myelomaGeorge E Georges, Michael B Maris, David G Maloney, et al.
British Journal of Haematology|April 22, 2005
Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantationMarco Mielcarek, Lauri Burroughs, Wendy Leisenring, et al.
Blood|October 4, 2003
Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioningWolfgang A Bethge, Ute Hegenbart, Monic J Stuart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2007
Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphomaAndrew R Rezvani, Barry Storer, Michael Maris, et al.
Blood|July 12, 2003
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myelomaDavid G Maloney, Arthur J Molina, Firoozeh Sahebi, et al.
Pageof 32

Showing results (261-270 of 315) with videos related to

Sort By:
Pageof 32
Blood|January 12, 2012
The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantationBart L Scott, Ted A Gooley, Mohamed L Sorror, et al.
Cancers|August 23, 2020
Conditioning Intensity, Pre-Transplant Flow Cytometric Measurable Residual Disease, and Outcome in Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell TransplantationLinde M Morsink, Brenda M Sandmaier, Megan Othus, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 12, 2010
Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia: relapse-free survival is determined by karyotype and comorbiditiesHesham Eissa, Ted A Gooley, Mohamed L Sorror, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 13, 2017
Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure DisordersLauri M Burroughs, Akiko Shimamura, Julie-An Talano, et al.
Blood|July 1, 2004
Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioningFrédéric Baron, Jennifer E Baker, Rainer Storb, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 9, 2007
Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myelomaGeorge E Georges, Michael B Maris, David G Maloney, et al.
British Journal of Haematology|April 22, 2005
Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantationMarco Mielcarek, Lauri Burroughs, Wendy Leisenring, et al.
Blood|October 4, 2003
Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioningWolfgang A Bethge, Ute Hegenbart, Monic J Stuart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2007
Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphomaAndrew R Rezvani, Barry Storer, Michael Maris, et al.
Blood|July 12, 2003
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myelomaDavid G Maloney, Arthur J Molina, Firoozeh Sahebi, et al.
Pageof 32